Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human TRAILR4/TNFRSF10D Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 9 publications
Supplier: R&D Systems AF633SP
This item is not returnable.
View return policy
Description
TRAILR4/TNFRSF10D/DcR2 Polyclonal specifically detects TRAILR4/TNFRSF10D/DcR2 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Neutralization, CyTOF-ready.Specifications
TRAILR4/TNFRSF10D/DcR2 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD264, CD264 antigen, DcR2, DCR2decoy with truncated death domain, Decoy receptor 2, TNF receptor-related receptor for TRAIL, TNF-related apoptosis-inducing ligand receptor 4, TNFRSF10D, TRAIL R4, TRAIL-R4, TRAILR4TRAIL receptor 4, TRUNDDTRAIL receptor with a truncated death domain, tumor necrosis factor receptor superfamily member 10D, tumor necrosis factor receptor superfamily, member 10d, decoy with truncateddeath domain | |
Goat | |
Affinity Purified | |
RUO | |
8793 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Neutralization, CyTOF | |
LYOPH | |
Western Blot 0.1 μg/mL, Flow Cytometry 2.5 ug/10^6 cells, ELISA, Immunohistochemistry 5-15 μg/mL, Neutralization 0.03-0.1 μg/mL, CyTOF-ready | |
Q9UBN6 | |
TNFRSF10D | |
Mouse myeloma cell line NS0-derived recombinant human TRAIL R4/TNFRSF10D Ala56-His211 Accession # Q9UBN6 | |
25 μg | |
Primary | |
Detects human TRAIL R4/TNFRSF10D in direct ELISAs and Western blots. In Western blots, less than 5% cross-reactivity with recombinant human (rh) TRAIL R1, rhTRAIL R2, and rhTRAIL R3 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction